10:59 AM EDT, 09/02/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were sharply lower late Tuesday morning, falling 1.12% to 1,504.34 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS ( EDAP ) and pharmaceutical company Ascendis Pharma ( ASND ) , which climbed 22% and 3.9%, respectively. They were followed by consumer goods company Unilever ( UL ) and petroleum refiner Equinor ( EQNR ) , which were up 0.6% each.

The decliners from continental Europe were led by biopharmaceutical companies Genfit ( GNFT ) and Grifols ( GRFS ) , which fell 4.1% and 3.2%, respectively. They were followed by internet advertising firm Criteo ( CRTO ) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 2.2% each.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Amarin ( AMRN ) and Mereo BioPharma Group ( MREO ) , which rose 3.9% each. They were followed by pharmaceutical company Silence Therapeutics ( SLN ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which were up 2.9% and 2.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and tobacco company British American Tobacco ( BTI ) , which dropped 21% and 3.9%, respectively. They were followed by cruise line operator Carnival (CUK) and utilities company National Grid ( NGG ) , which were down 3.4% each.